NASDAQ: SRZNSurrozen Inc Stock Ownership - Who owns Surrozen?
Insider buying vs selling
Have Surrozen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Charles O. Williams | Chief Financial Officer | 2023-06-15 | 25,000 | $0.38 | $9.50kBuy |
| Craig C. Parker | Chief Executive Officer | 2023-06-15 | 25,000 | $0.38 | $9.50kBuy |
| Wenchen Yeh | Chief Scientific Officer | 2023-06-15 | 17,638 | $0.38 | $6.70kBuy |
| Wenchen Yeh | Chief Scientific Officer | 2022-12-15 | 9,578 | $0.41 | $3.93kBuy |
| Charles O. Williams | Chief Financial Officer | 2022-12-15 | 9,578 | $0.41 | $3.93kBuy |
| Geertrui Vanhove | Chief Medical Officer | 2022-12-15 | 9,578 | $0.41 | $3.93kBuy |
| Craig C. Parker | Chief Executive Officer | 2022-12-15 | 9,578 | $0.41 | $3.93kBuy |
SRZN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SRZN insiders and whales buy or sell their stock.
SRZN Shareholders
What type of owners hold Surrozen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Column Group LLC | 30.79% | 9,414,795 | $4.85M | Institution |
| Column Group Iii GP LP | 30.25% | 9,248,129 | $4.76M | Insider |
| Tim Kutzkey | 30.25% | 9,248,129 | $4.76M | Insider |
| Kevin Harold Livingston | 13.39% | 4,095,000 | $2.11M | Insider |
| Benny Soffer | 13.39% | 4,095,000 | $2.11M | Insider |
| Life Sciences Consonance | 13.39% | 4,095,000 | $2.11M | Insider |
| Mitchell J. Md Blutt | 8.65% | 2,644,000 | $1.36M | Insider |
| Euclidean Capital LLC | 4.30% | 1,315,463 | $677.46k | Institution |
| Blackrock Inc | 3.49% | 1,068,571 | $550.31k | Institution |
| Harvard Management Co Inc | 2.70% | 826,852 | $425.83k | Institution |
SRZN vs Biotech Stocks
Surrozen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.